98%
921
2 minutes
20
Purpose: To characterize two patients with macular and rod-cone dystrophy and identify the genetic basis for disease.
Method: Ophthalmic examinations were performed for the family and the peripheral blood samples were collected for whole exome sequencing. The mutated sequences of PROM1 gene were cloned and expressed in cultured cell lines after transient transfection followed by analysis with confocal microscopy and bridge-PCR.
Result: We reported that two patients, brothers in a family, were diagnosed with macular and rod-cone dystrophy. Phenotypically, both patients experience progressive visual impairment and nyctalopia. The fundus examination showed macular and choroid dystrophy with pigment deposits in the macular region. Functionally, photoreceptor response to electrophysiological stimulation was significantly compromised with more severe decline in rods. Genetic analysis by whole exome sequencing revealed two novel compound heterogeneous point mutations in PROM1 gene that co-segregate with patients in an autosomal recessive manner. Specifically, the c.C1902G(p.Y634X) nonsense mutation results in a truncated, labile, and mislocalized protein, while the c.C1682+3A>G intronic mutation disrupts messenger RNA splicing.
Conclusion: Our findings have identified two novel deleterious mutations in PROM1 gene that are associated with hereditary macular and rod-cone dystrophy in human.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00417-018-04206-w | DOI Listing |
BMC Med Genomics
August 2025
Department of Ophthalmology, Duke University, 2351 Erwin Rd, Durham, NC, 27710, USA.
Background: Inherited retinal diseases (IRDs) are a group of heterogeneous conditions leading to visual impairment and blindness with over 280 associated genes identified so far. This study aims to provide an initial characterization of the clinical and genetic landscape of IRDs in the United States with a cohort from Kentucky and contribute to the existing knowledge from studies in other regions.
Methods: This single-academic center retrospective analysis was conducted on patients seen at the University of Kentucky Ophthalmic Genetic Services from January 2019 to March 2022 with a diagnosis of or concern for unspecified IRD and who underwent subsequent genetic testing with an IRD panel.
Am J Ophthalmol
August 2025
UCL Institute of Ophthalmology, University College London, London, UK; Moorfields Eye Hospital NHS Foundation Trust, London, UK. Electronic address:
Purpose: To analyze the clinical spectrum and natural history of SNRNP200-associated retinopathy.
Design: Multi-center retrospective, observational cohort study.
Patients: Molecularly confirmed patients with at least one disease-causing variant in SNRNP200.
Mol Biol Rep
August 2025
Genomics and Human Genetics Laboratory, Institut Pasteur du Maroc, 1 Place Louis Pasteur, Casablanca, 20360, Morocco.
Background: Inherited retinal dystrophies (IRD) are a group of conditions resulting in visual impairments or blindness, due to the dysfunction of the retina. It affects 1/2000 individuals worldwide, and over 324 genes and 20 phenotypes are implicated in these pathologies. The most common form of IRD is Retinitis Pigmentosa, followed by Stargardt diseases, Leber congenital amaurosis and cone/cone-rod dystrophies.
View Article and Find Full Text PDFAm J Ophthalmol
August 2025
Vanderbilt Eye Institute (L.M.S., K.M.J.), Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biomedical Engineering (K.M.J.), Vanderbilt University, Nashville, Tennessee, USA. Electronic address:
Purpose: The multicenter NIH-funded Undiagnosed Diseases Network (UDN) exists to diagnose puzzling and newly discovered conditions. We report the UDN's assistance in diagnosing perplexing ocular disorders along with 6 case illustrations.
Design: Retrospective Interventional Case Series.
Adv Exp Med Biol
July 2025
Department of Ophthalmology, Columbia University, New York, NY, USA.
Alström syndrome is an autosomal recessive disease with multisystem involvement, including cone-rod dystrophy, hearing loss, type 2 diabetes, insulin resistance with hyperinsulinemia, dilated cardiomyopathy, and progressive hepatic and renal failure.
View Article and Find Full Text PDF